119 related articles for article (PubMed ID: 38833838)
1. Retraction notice to "Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter" [EBioMedicine 55 (2020) 102694].
Ou M; Li X; Zhao S; Cui S; Tu J
EBioMedicine; 2024 Jun; 104():105193. PubMed ID: 38833838
[No Abstract] [Full Text] [Related]
2. Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter.
Ou M; Li X; Zhao S; Cui S; Tu J
EBioMedicine; 2020 May; 55():102694. PubMed ID: 32335370
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression.
Li H; Han S; Sun Q; Yao Y; Li S; Yuan C; Zhang B; Jing B; Wu J; Song Y; Wang H
Aging (Albany NY); 2019 Mar; 11(6):1695-1715. PubMed ID: 30926762
[TBL] [Abstract][Full Text] [Related]
4. CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases.
Song C; Qi Y; Zhang J; Guo C; Yuan C
Curr Pharm Des; 2020; 26(41):5335-5346. PubMed ID: 32767927
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CDKN2B-AS1 promotes hepatocellular carcinoma progression
Tao ZG; Yuan YX; Wang GW
World J Gastrointest Oncol; 2023 Nov; 15(11):1974-1987. PubMed ID: 38077646
[TBL] [Abstract][Full Text] [Related]
6. Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation.
Rankin CR; Lokhandwala ZA; Huang R; Pekow J; Pothoulakis C; Padua D
Life Sci; 2019 Aug; 231():116571. PubMed ID: 31207308
[TBL] [Abstract][Full Text] [Related]
7. lncRNA CDKN2B-AS1 regulates collagen expression.
Shi W; Song J; Weiner JM; Chopra A; Dommisch H; Beule D; Schaefer AS
Hum Genet; 2024 Jun; ():. PubMed ID: 38833008
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CDKN2B-AS1 enhances LPS-induced apoptotic and inflammatory damages in human lung epithelial cells via regulating the miR-140-5p/TGFBR2/Smad3 signal network.
Wang B; Sun Q; Ye W; Li L; Jin P
BMC Pulm Med; 2021 Jun; 21(1):200. PubMed ID: 34126975
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA CDKN2B-AS1 Facilitates Laryngeal Squamous Cell Cancer Through Regulating miR-497/CDK6 Pathway.
Cui X; Yu T; Shang J; Xiao D; Wang X
Onco Targets Ther; 2019; 12():8853-8862. PubMed ID: 31754305
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA CDKN2B-AS1 silencing protects against esophageal cancer cell invasion and migration by inactivating the TFAP2A/FSCN1 axis.
Zhu JL; Xue WB; Jiang ZB; Feng W; Liu YC; Nie XY; Jin LY
Kaohsiung J Med Sci; 2022 Dec; 38(12):1144-1154. PubMed ID: 36161699
[TBL] [Abstract][Full Text] [Related]
11. Effects of CDKN2B-AS1 on cellular proliferation, invasion and AKT3 expression are attenuated by miR-424-5p in a model of ovarian endometriosis.
Wang S; Yi M; Zhang X; Zhang T; Jiang L; Cao L; Zhou Y; Fang X
Reprod Biomed Online; 2021 Jun; 42(6):1057-1066. PubMed ID: 33820740
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458.
Gui D; Cao H
In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):24-33. PubMed ID: 31950433
[TBL] [Abstract][Full Text] [Related]
13. Regulation of glial cell-derived neurotrophic factor in sevoflurane-induced neuronal apoptosis by long non-coding RNA CDKN2B-AS1 as a ceRNA to adsorb miR-133.
Jiang S; Wang C; Zhu J; Huang X
Am J Transl Res; 2021; 13(5):4760-4770. PubMed ID: 34150056
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CDKN2B-AS1 regulates high glucose-induced human mesangial cell injury via regulating the miR-15b-5p/WNT2B axis.
Chang J; Yu Y; Fang Z; He H; Wang D; Teng J; Yang L
Diabetol Metab Syndr; 2020 Dec; 12(1):109. PubMed ID: 33298110
[TBL] [Abstract][Full Text] [Related]
15. The stimulative function of long noncoding RNA CDKN2B-AS1 in osteosarcoma by targeting the microRNA-122/CCNG1 axis.
Abula A; Saimaiti G; Maimaiti X; Wuqikun W; Abulaiti A; Ren P; Yusufu A
J Recept Signal Transduct Res; 2022 Feb; 42(1):71-79. PubMed ID: 33283575
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of lncRNA CDKN2B-AS1 attenuates inflammatory response in mice with allergic rhinitis by regulating miR-98-5p/SOCS1 axis.
Deng B; Zhao Y; Liu J
Funct Integr Genomics; 2024 Mar; 24(2):48. PubMed ID: 38436805
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis.
Huang Y; Xiang B; Liu Y; Wang Y; Kan H
Cancer Lett; 2018 Nov; 437():56-66. PubMed ID: 30165194
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CDKN2B-AS1 contributes to tumorigenesis and chemoresistance in pediatric T-cell acute lymphoblastic leukemia through miR-335-3p/TRAF5 axis.
Chen L; Shi Y; Li J; Yang X; Li R; Zhou X; Zhu L
Anticancer Drugs; 2020 Sep; ():. PubMed ID: 32976214
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription.
Lei JJ; Li HQ; Mo ZH; Liu KJ; Zhu LJ; Li CY; Chen WL; Zhang L
FASEB J; 2019 Jun; 33(6):7037-7048. PubMed ID: 30870006
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA cyclin-dependent kinase inhibitor 2B antisense ribonucleic acid 1 is associated with in-stent restenosis and promotes human carotid artery smooth muscle cell proliferation and migration by sponging miR-143-3p.
Ma H; Dong A
Exp Ther Med; 2021 Mar; 21(3):234. PubMed ID: 33603842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
